Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,477.16
(
-1.74%
)
US TECH 100
23,040.00
(
-2.01%
)
Dow Jones
45,960.11
(
-1.01%
)
Brent Oil
100.96
(
0.28%
)
Bitcoin
68,819.62
(
0.05%
)
News Focus
News Focus
Post# of 8473
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 91
Posts 20563
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: akasidney86 post# 3526

Thursday, 02/28/2008 11:48:00 AM

Thursday, February 28, 2008 11:48:00 AM

Post# of 8473
"..Zero risk trial.."

Actually, dewophile was refering to the drug being safe and effective in the anemia indication. This is far different than handicapping the aproval path via this trial.

. no SPA
. 15 patients on the placebo arm
. a (presumed) Eastern European trial

Certainly NONE of these are high concerns, but they certainly do add doubt past dewophiles expectationcies for the drug itself.

It is a very safe bet that in general (not directed at RPRX here) investor optimisim is far too high in this setting.


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent RPRX News
More RPRX News
InvestorsHub NewsWire

The Crypto Company Acquires FRAME Blockchain's Technology, An "Interstate Highway" Liquidity Layer for Crypto Commerce • CRCW • Mar 26, 2026 12:28 PM

Resilient Energy Inc. Enters LOI Negtiations for Second Acquisition; First Acquisition Nears Closing • RENI • Mar 26, 2026 10:30 AM

Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report • ACGX • Mar 26, 2026 8:30 AM

Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase • OWPC • Mar 25, 2026 9:07 AM

ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • ECGI • Mar 24, 2026 8:30 AM

Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM

Start posting your company's news
Only $200 per official company press release!